Copyright Reports & Markets. All rights reserved.

Global Automation in Biopharmaceutical Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Automation in Biopharmaceutical Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Clinical Stage Automation
    • 1.2.3 Drug Discovery Stage Automation
  • 1.3 Market by Application
    • 1.3.1 Global Automation in Biopharmaceutical Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Research and Development
    • 1.3.3 Clinical
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Automation in Biopharmaceutical Market Perspective (2016-2027)
  • 2.2 Automation in Biopharmaceutical Growth Trends by Regions
    • 2.2.1 Automation in Biopharmaceutical Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Automation in Biopharmaceutical Historic Market Share by Regions (2016-2021)
    • 2.2.3 Automation in Biopharmaceutical Forecasted Market Size by Regions (2022-2027)
  • 2.3 Automation in Biopharmaceutical Industry Dynamic
    • 2.3.1 Automation in Biopharmaceutical Market Trends
    • 2.3.2 Automation in Biopharmaceutical Market Drivers
    • 2.3.3 Automation in Biopharmaceutical Market Challenges
    • 2.3.4 Automation in Biopharmaceutical Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Automation in Biopharmaceutical Players by Revenue
    • 3.1.1 Global Top Automation in Biopharmaceutical Players by Revenue (2016-2021)
    • 3.1.2 Global Automation in Biopharmaceutical Revenue Market Share by Players (2016-2021)
  • 3.2 Global Automation in Biopharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Automation in Biopharmaceutical Revenue
  • 3.4 Global Automation in Biopharmaceutical Market Concentration Ratio
    • 3.4.1 Global Automation in Biopharmaceutical Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Automation in Biopharmaceutical Revenue in 2020
  • 3.5 Automation in Biopharmaceutical Key Players Head office and Area Served
  • 3.6 Key Players Automation in Biopharmaceutical Product Solution and Service
  • 3.7 Date of Enter into Automation in Biopharmaceutical Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Automation in Biopharmaceutical Breakdown Data by Type

  • 4.1 Global Automation in Biopharmaceutical Historic Market Size by Type (2016-2021)
  • 4.2 Global Automation in Biopharmaceutical Forecasted Market Size by Type (2022-2027)

5 Automation in Biopharmaceutical Breakdown Data by Application

  • 5.1 Global Automation in Biopharmaceutical Historic Market Size by Application (2016-2021)
  • 5.2 Global Automation in Biopharmaceutical Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Automation in Biopharmaceutical Market Size (2016-2027)
  • 6.2 North America Automation in Biopharmaceutical Market Size by Type
    • 6.2.1 North America Automation in Biopharmaceutical Market Size by Type (2016-2021)
    • 6.2.2 North America Automation in Biopharmaceutical Market Size by Type (2022-2027)
    • 6.2.3 North America Automation in Biopharmaceutical Market Size by Type (2016-2027)
  • 6.3 North America Automation in Biopharmaceutical Market Size by Application
    • 6.3.1 North America Automation in Biopharmaceutical Market Size by Application (2016-2021)
    • 6.3.2 North America Automation in Biopharmaceutical Market Size by Application (2022-2027)
    • 6.3.3 North America Automation in Biopharmaceutical Market Size by Application (2016-2027)
  • 6.4 North America Automation in Biopharmaceutical Market Size by Country
    • 6.4.1 North America Automation in Biopharmaceutical Market Size by Country (2016-2021)
    • 6.4.2 North America Automation in Biopharmaceutical Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.3 Canada

7 Europe

  • 7.1 Europe Automation in Biopharmaceutical Market Size (2016-2027)
  • 7.2 Europe Automation in Biopharmaceutical Market Size by Type
    • 7.2.1 Europe Automation in Biopharmaceutical Market Size by Type (2016-2021)
    • 7.2.2 Europe Automation in Biopharmaceutical Market Size by Type (2022-2027)
    • 7.2.3 Europe Automation in Biopharmaceutical Market Size by Type (2016-2027)
  • 7.3 Europe Automation in Biopharmaceutical Market Size by Application
    • 7.3.1 Europe Automation in Biopharmaceutical Market Size by Application (2016-2021)
    • 7.3.2 Europe Automation in Biopharmaceutical Market Size by Application (2022-2027)
    • 7.3.3 Europe Automation in Biopharmaceutical Market Size by Application (2016-2027)
  • 7.4 Europe Automation in Biopharmaceutical Market Size by Country
    • 7.4.1 Europe Automation in Biopharmaceutical Market Size by Country (2016-2021)
    • 7.4.2 Europe Automation in Biopharmaceutical Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Automation in Biopharmaceutical Market Size (2016-2027)
  • 8.2 Asia-Pacific Automation in Biopharmaceutical Market Size by Type
    • 8.2.1 Asia-Pacific Automation in Biopharmaceutical Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Automation in Biopharmaceutical Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Automation in Biopharmaceutical Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Automation in Biopharmaceutical Market Size by Application
    • 8.3.1 Asia-Pacific Automation in Biopharmaceutical Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Automation in Biopharmaceutical Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Automation in Biopharmaceutical Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Automation in Biopharmaceutical Market Size by Region
    • 8.4.1 Asia-Pacific Automation in Biopharmaceutical Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Automation in Biopharmaceutical Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Automation in Biopharmaceutical Market Size (2016-2027)
  • 9.2 Latin America Automation in Biopharmaceutical Market Size by Type
    • 9.2.1 Latin America Automation in Biopharmaceutical Market Size by Type (2016-2021)
    • 9.2.2 Latin America Automation in Biopharmaceutical Market Size by Type (2022-2027)
    • 9.2.3 Latin America Automation in Biopharmaceutical Market Size by Type (2016-2027)
  • 9.3 Latin America Automation in Biopharmaceutical Market Size by Application
    • 9.3.1 Latin America Automation in Biopharmaceutical Market Size by Application (2016-2021)
    • 9.3.2 Latin America Automation in Biopharmaceutical Market Size by Application (2022-2027)
    • 9.3.3 Latin America Automation in Biopharmaceutical Market Size by Application (2016-2027)
  • 9.4 Latin America Automation in Biopharmaceutical Market Size by Country
    • 9.4.1 Latin America Automation in Biopharmaceutical Market Size by Country (2016-2021)
    • 9.4.2 Latin America Automation in Biopharmaceutical Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Automation in Biopharmaceutical Market Size (2016-2027)
  • 10.2 Middle East & Africa Automation in Biopharmaceutical Market Size by Type
    • 10.2.1 Middle East & Africa Automation in Biopharmaceutical Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Automation in Biopharmaceutical Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Automation in Biopharmaceutical Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Automation in Biopharmaceutical Market Size by Application
    • 10.3.1 Middle East & Africa Automation in Biopharmaceutical Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Automation in Biopharmaceutical Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Automation in Biopharmaceutical Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Automation in Biopharmaceutical Market Size by Country
    • 10.4.1 Middle East & Africa Automation in Biopharmaceutical Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Automation in Biopharmaceutical Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Danaher
    • 11.1.1 Danaher Company Details
    • 11.1.2 Danaher Business Overview
    • 11.1.3 Danaher Automation in Biopharmaceutical Introduction
    • 11.1.4 Danaher Revenue in Automation in Biopharmaceutical Business (2016-2021)
    • 11.1.5 Danaher Recent Development
  • 11.2 GE
    • 11.2.1 GE Company Details
    • 11.2.2 GE Business Overview
    • 11.2.3 GE Automation in Biopharmaceutical Introduction
    • 11.2.4 GE Revenue in Automation in Biopharmaceutical Business (2016-2021)
    • 11.2.5 GE Recent Development
  • 11.3 PerkinElmer
    • 11.3.1 PerkinElmer Company Details
    • 11.3.2 PerkinElmer Business Overview
    • 11.3.3 PerkinElmer Automation in Biopharmaceutical Introduction
    • 11.3.4 PerkinElmer Revenue in Automation in Biopharmaceutical Business (2016-2021)
    • 11.3.5 PerkinElmer Recent Development
  • 11.4 Tecan Trading
    • 11.4.1 Tecan Trading Company Details
    • 11.4.2 Tecan Trading Business Overview
    • 11.4.3 Tecan Trading Automation in Biopharmaceutical Introduction
    • 11.4.4 Tecan Trading Revenue in Automation in Biopharmaceutical Business (2016-2021)
    • 11.4.5 Tecan Trading Recent Development
  • 11.5 Thermo Fisher Scientific
    • 11.5.1 Thermo Fisher Scientific Company Details
    • 11.5.2 Thermo Fisher Scientific Business Overview
    • 11.5.3 Thermo Fisher Scientific Automation in Biopharmaceutical Introduction
    • 11.5.4 Thermo Fisher Scientific Revenue in Automation in Biopharmaceutical Business (2016-2021)
    • 11.5.5 Thermo Fisher Scientific Recent Development
  • 11.6 Bruker
    • 11.6.1 Bruker Company Details
    • 11.6.2 Bruker Business Overview
    • 11.6.3 Bruker Automation in Biopharmaceutical Introduction
    • 11.6.4 Bruker Revenue in Automation in Biopharmaceutical Business (2016-2021)
    • 11.6.5 Bruker Recent Development
  • 11.7 Peak Analysis and Automation
    • 11.7.1 Peak Analysis and Automation Company Details
    • 11.7.2 Peak Analysis and Automation Business Overview
    • 11.7.3 Peak Analysis and Automation Automation in Biopharmaceutical Introduction
    • 11.7.4 Peak Analysis and Automation Revenue in Automation in Biopharmaceutical Business (2016-2021)
    • 11.7.5 Peak Analysis and Automation Recent Development
  • 11.8 Waters
    • 11.8.1 Waters Company Details
    • 11.8.2 Waters Business Overview
    • 11.8.3 Waters Automation in Biopharmaceutical Introduction
    • 11.8.4 Waters Revenue in Automation in Biopharmaceutical Business (2016-2021)
    • 11.8.5 Waters Recent Development
  • 11.9 Capsugel
    • 11.9.1 Capsugel Company Details
    • 11.9.2 Capsugel Business Overview
    • 11.9.3 Capsugel Automation in Biopharmaceutical Introduction
    • 11.9.4 Capsugel Revenue in Automation in Biopharmaceutical Business (2016-2021)
    • 11.9.5 Capsugel Recent Development
  • 11.10 RheoSense
    • 11.10.1 RheoSense Company Details
    • 11.10.2 RheoSense Business Overview
    • 11.10.3 RheoSense Automation in Biopharmaceutical Introduction
    • 11.10.4 RheoSense Revenue in Automation in Biopharmaceutical Business (2016-2021)
    • 11.10.5 RheoSense Recent Development
  • 11.11 Eirechrom
    • 11.11.1 Eirechrom Company Details
    • 11.11.2 Eirechrom Business Overview
    • 11.11.3 Eirechrom Automation in Biopharmaceutical Introduction
    • 11.11.4 Eirechrom Revenue in Automation in Biopharmaceutical Business (2016-2021)
    • 11.11.5 Eirechrom Recent Development
  • 11.12 BioProcess International
    • 11.12.1 BioProcess International Company Details
    • 11.12.2 BioProcess International Business Overview
    • 11.12.3 BioProcess International Automation in Biopharmaceutical Introduction
    • 11.12.4 BioProcess International Revenue in Automation in Biopharmaceutical Business (2016-2021)
    • 11.12.5 BioProcess International Recent Development
  • 11.13 Novasep
    • 11.13.1 Novasep Company Details
    • 11.13.2 Novasep Business Overview
    • 11.13.3 Novasep Automation in Biopharmaceutical Introduction
    • 11.13.4 Novasep Revenue in Automation in Biopharmaceutical Business (2016-2021)
    • 11.13.5 Novasep Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Automation in Biopharmaceutical market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Automation in Biopharmaceutical market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Clinical Stage Automation
    Drug Discovery Stage Automation

    Segment by Application
    Research and Development
    Clinical

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Danaher
    GE
    PerkinElmer
    Tecan Trading
    Thermo Fisher Scientific
    Bruker
    Peak Analysis and Automation
    Waters
    Capsugel
    Tecan Trading
    Thermo Fisher Scientific
    BioProcess International

    Buy now